Tobramycin 3-(4-(6-Maleimido)hexyl)amino)-4-oxo)butanoate

Nazwa analitu

N'-(((2R,3S,5R,6R)-5-amino-6-((1R,2S,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2-hydroxycyclohexyl)oxy-3-hydroxyoxan-2-yl)methyl)-N-(6-(2,5-dioxopyrrol-1-yl)hexyl)butanediamide

Wzór cząsteczkowy

C32 H55 N7 O13

Masa cząsteczkowa

745.818

Dokładna masa

745.386

SMILES

N[C@@H]1C[C@H](O)[C@@H](CNC(=O)CCC(=O)NCCCCCCN2C(=O)C=CC2=O)O[C@@H]1O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](N)[C@H]4O)[C@H]3O

InChI

InChI=1S/C32H55N7O13/c33-15-11-16(34)30(52-32-27(47)25(36)26(46)20(14-40)50-32)28(48)29(15)51-31-17(35)12-18(41)19(49-31)13-38-22(43)6-5-21(42)37-9-3-1-2-4-10-39-23(44)7-8-24(39)45/h7-8,15-20,25-32,40-41,46-48H,1-6,9-14,33-36H2,(H,37,42)(H,38,43)/t15-,16+,17+,18-,19+,20+,25-,26+,27+,28-,29+,30-,31+,32+/m0/s1

IUPAC

N'-[[(2R,3S,5R,6R)-5-amino-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3-hydroxyoxan-2-yl]methyl]-N-[6-(2,5-dioxopyrrol-1-yl)hexyl]butanediamide

Temperatura podczas transportu

Room Temperature

Kraj pochodzenia

CANADA

Postać produktu

Neat